SOX4, LGR5, AXIN2, cMYC, and this signature, together with tumor cell proliferation, are abrogated in vitro by the inhibition of TCF function through dominant-negative TCF (dnTCF4) expression. This evidence concerns the gene AXIN2 and neoplasm.